+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Table of Contents
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Medical Morphine MARKET, BY Route of Administration
6.1. Overview
6.2. Oral
6.3. Injectables
7. GLOBAL Medical Morphine MARKET, BY Distribution Channel
7.1. Overview
7.2. Hospital Pharmacy
7.3. Online Pharmacy
7.4. Retail Pharmacy
7.5. Others
8. GLOBAL Medical Morphine MARKET, BY Application
8.1. Overview
8.2. Myocardial Infarction
8.3. Diarrhea
8.4. Arthritis
8.5. Kidney Stones
8.6. Cancer
8.7. Others
9. GLOBAL Medical Morphine MARKET, BY End User
9.1. Overview
9.2. Hospitals and Clinics
9.3. Ambulatory Surgical Centers
9.4. Home Care
10. GLOBAL Medical Morphine MARKET, by Region
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. South Korea
10.4.5. Australia
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
10.5.3. Latin America
11. Competitive Landscape
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Medical Morphine Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Medical Morphine Market,
11.7. Key developments and Growth Strategies
11.7.1. New Route of Administration Launch/Distribution Channel Application
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. Company ProfileS
12.1. ALCALIBER S.A PFIZER INC.
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Route of Administrations Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Taj Pharmaceuticals Limited.
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Route of Administrations Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. TAJ PHARMACEUTICALS LIMITED.
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Route of Administrations Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. MANUS AKTTEVA BIOPHARMA LLP
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Route of Administrations Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Mallinckrodt Pharmaceuticals.
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Route of Administrations Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. PURDUE PHARMA L.P..
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Route of Administrations Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Johnson Matthey Fine Chemicals
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Route of Administrations Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Verve Health Care Ltd..
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Route of Administrations Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. NORTHEAST PHARM.
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Route of Administrations Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
13. Appendix
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 Global Medical Morphine Market, Synopsis, 2018-2032
TABLE 2 Global Medical Morphine Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 7 North America Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 8 North America Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 9 North America Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 10 North America Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 11 North America Medical Morphine MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 12 U.S. Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 13 U.S. Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 14 U.S. Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 U.S. Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 16 Canada Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 17 Canada Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 18 Canada Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 19 Canada Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 20 Europe Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 21 Europe Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 22 Europe Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 Europe Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 24 Europe Medical Morphine MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 25 Germany Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 26 Germany Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 27 Germany Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 28 Germany Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 29 France Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 30 France Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 31 France Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 32 France Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 33 Italy Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 34 Italy Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 35 Italy Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 36 Italy Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 37 Spain Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 38 Spain Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 39 Spain Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 40 Spain Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 41 U.K Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 42 U.K Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 43 U.K Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 44 U.K Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 45 Rest of Europe Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 46 Rest of Europe Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 47 Rest of Europe Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 48 Rest of Europe Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 49 Asia Pacific Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 50 Asia Pacific Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 51 Asia Pacific Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 52 Asia Pacific Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 53 Asia Pacific Medical Morphine MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 54 Japan Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 55 Japan Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 56 Japan Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 57 Japan Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 58 China Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 59 China Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 60 China Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 61 China Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 62 India Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 63 India Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 64 India Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 65 India Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 66 Australia Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 67 Australia Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 68 Australia Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 69 Australia Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 70 south korea Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 71 south korea Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 72 south korea Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 73 south korea Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 74 Rest of asia-pacific Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 75 Rest of asia-pacific Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 76 Rest of asia-pacific Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 77 Rest of asia-pacific Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 78 Rest of WOrld Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 79 Rest of WOrld Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 80 Rest of WOrld Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 81 Rest of WOrld Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 82 Rest of WOrld Medical Morphine MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 83 Middle east Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 84 Middle east Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 85 Middle east Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 86 Middle east Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 87 Africa Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 88 Africa Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 89 Africa Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 90 Africa Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 91 Latin america Medical Morphine MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 92 Latin america Medical Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 93 Latin america Medical Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 94 Latin america Medical Morphine MARKET, BY END USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Medical Morphine Market
FIGURE 3 Market Dynamics for the Global Medical Morphine Market
FIGURE 4 Global Medical Morphine Market, Share (%), BY Route of Administration, 2022
FIGURE 5 Global Medical Morphine Market, Share (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 6 Global Medical Morphine Market, Share (%), BY APPLICATION, 2022
FIGURE 7 Global Medical Morphine Market, Share (%), BY END USER, 2022
FIGURE 8 Global Medical Morphine Market, Share (%), by Region, 2022
FIGURE 9 north AMERICA: Medical Morphine MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Europe: Medical Morphine MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Asia-Pacific: Medical Morphine MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 Rest of the world: Medical Morphine MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 Global Medical Morphine Market: Company Share Analysis, 2022 (%)
FIGURE 14 ALCALIBER S.A PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 ALCALIBER S.A PFIZER INC.: SWOT ANALYSIS
FIGURE 16 Taj Pharmaceuticals Limited.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 Taj Pharmaceuticals Limited.: SWOT ANALYSIS
FIGURE 18 TAJ PHARMACEUTICALS LIMITED.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 TAJ PHARMACEUTICALS LIMITED.: SWOT ANALYSIS
FIGURE 20 MANUS AKTTEVA BIOPHARMA LLP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 MANUS AKTTEVA BIOPHARMA LLP: SWOT ANALYSIS
FIGURE 22 Mallinckrodt Pharmaceuticals..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 Mallinckrodt Pharmaceuticals..: SWOT ANALYSIS
FIGURE 24 PURDUE PHARMA L.P..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 PURDUE PHARMA L.P..: SWOT ANALYSIS
FIGURE 26 Johnson Matthey Fine Chemicals: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 Johnson Matthey Fine Chemicals: SWOT ANALYSIS
FIGURE 28 Verve Health Care Ltd..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 Verve Health Care Ltd..: SWOT ANALYSIS
FIGURE 30 NORTHEAST PHARM.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 NORTHEAST PHARM.: SWOT ANALYSIS
Report Code :
RL6548
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst